3 ms·
Probably referring to the ARB (angiotensin receptor blocker) shortages. Basically, an API manufacturer changed up its process, but it turned out to generate ve
by Scoundreller 7y ago
Probably referring to the ARB (angiotensin receptor blocker) shortages.
Basically, an API manufacturer changed up its process, but it turned out to generate very small quantities of a very small molecule side-product that’s carcinogenic.
NDMA and NDEA.
https://www.google.com/search?q=arb+ndma https://www.google.com/search?q=arb+ndma